Concepedia

5501 ORAL Cetuximab plus platinum-based therapy first-line in recurrent and/or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Efficacy and safety results of a randomized phase III trial (EXTREME)

Jan B. Vermorken, Ricardo Hitt, Lionnel Geoffrois, J. Erfán, Andrzej Kawecki, D. Zabolotnyy, Armin Schueler, Raimald Knecht, Marco Benasso, H. Kienzer

European Journal of Cancer Supplements · 2007 · 18 citations · 0 references

DOI

Concepts